产品帮助中心

搜索结果:

Mr. Z

For me now, health is everything. It is far from my personal business, it is vital to my family, my work. Thanks to the founder of Apaike, although I don’t know you, but because of your project, saved my life, thank you!

Ms. Z

Thank you very much for the advanced technology of Apake Company, which found my hidden dangers in advance, so that I have a healthy body and a happy mood to continue to work and live.

Ms. S

I’m glad I caught it so early, and now I’m on a conservative regimen, with check-ups every three months. Thanks to “APicco” technology, thanks to expert doctors…

Core Team

Company Founder Dr. Chris Yu Founder/Chairman Dr. Chris YuFounder/Chairman Born to a medical doctor’s family, he was admitted to Shanghai Second Medical College, and later switched to physics major, receiving a Ph.D. degree in physics from Pennsylvania State University in the US He is an inventor of more than 300 patents, out of which 200 have been issued Over the years, innovative and game changing products developed by Dr. Yu and his team have been highly successful globally, generating more than 5 billion US dollars in revenue One of the first scientists proposed the concept and method of multi-cancer screening

Home

Anpac Bio Founded in 2010 by interdisciplinary scientists and experts in the fields of medicine, physics, biology, biochemistry, nano-technology, etc., Anpac Bio is considered as one of the pioneers and leaders of multi(pan)-cancer detection, as well as an early inventor and developer in multi-level and multi-parameter cancer screening technology. Over the past decade, Anpac Bio has focused on break-through innovations, with a multi-disciplinary approach combining nano-technology, biophysical and biomedical technologies, and has overcome the technical challenges of early cancer screening. Anpac Bio has been carrying out multi-cancer detection tests using its novel and patented cancer differentiation analysis technology (CDA) for

Home

ANPAC Founded in 2010 by interdisciplinary scientists and expert returnees in the fields of medicine, physics, biochemistry, etc., ANPAC is considered as one of the pioneers and main leaders of multi(pan)-cancer detection and multi-dimensional multi-parameter cancer screening theories and methods. Over the past decade, ANPAC has focused on major innovation, with a multi-disciplinary approach combining biochips, biophysical and biomedical technologies, ANPAC has overcome the technical challenges of early cancer screening. more CDA Early Cancer Risk Assessment CDA and Gene combination test APCS Pan-Cancer Screening CDA and Gene combination test ADME Third Immune Defense Test CDA and Gene combination test MORE